Delivery Order SPE2DB24D1006-SPE2DB25FCEYG
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $5,822.80 for TWINRIX vaccine syringes (1mL, 10-count units) under a firm fixed-price contract. The award, issued on August 1, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive, non-set-aside procurement. This delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,502.89 delivery order on July 21, 2025, for Twinrix vaccine in syringe form, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,276.90 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement with an ultimate completion date of July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order as part of its ongoing federal medical procurement activities...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $149,035.14 for TWINRIX vaccine in syringe format on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a direct fulfillment of pharmaceutical medical supply needs through the federal procurement process. The contract is performed at AmerisourceBergen's corporate office location...
- This is a $10,103.55 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the procurement of TWINRIX VACCINE SYRINGEML. The contract has an ultimate completion date of April 3, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. This contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $98,326.08 firm fixed-price delivery order is for the supply of TWINRIX vaccine syringes. The contract has an ultimate completion date of May 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle...
- The Defense Logistics Agency awarded a $9,089.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine in syringe format on August 13, 2025, with completion targeted for August 14, 2025. The contract represents a small-value pharmaceutical supply transaction to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of TWINRIX vaccine syringes. The contract, valued at $1,846.48, has a completion date of July 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,396.10 to AmerisourceBergen Drug Corp for TWINRIX vaccine syringes on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $91,647.30 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This competitively awarded, firm fixed-price contract was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- SPE2DB24D1006Indefinite Delivery Contract
- SPE2DB24D1006-SPE2DB25FCEYGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,707.70 to AmerisourceBergen Drug Corp for TWINRIX vaccine in syringe format. This is a firm fixed price, competitively awarded contract with no set-aside designation, with a completion date of July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally, including customers such as the Defense Health Agency and U.S. Coast Guard. The company's contract portfolio demonstrates consistent capability to fulfill federal medical supply requirements through competitive procurement across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 7/28/25 |